CD8+ Cancer Research Results
CD8+, CD8+ T cell: Click to Expand ⟱
| Source: |
| Type: T cell |
CD8+ T cells are "end effectors" of cancer immunity.
Cytotoxic T cells expressing cell-surface CD8 are the most powerful effectors in the anticancer immune response and form the backbone of current successful cancer immunotherapies.
CD8+ T cells, also known as cytotoxic T lymphocytes (CTLs), play a crucial role in the immune response against cancer. They are responsible for identifying and killing cancer cells that present abnormal antigens, which can arise from mutations or viral infections.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-453 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
NF-kB↓, AntiTum↑, tumCV↓, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, TumCG↓, OS↑, TumMeta↓, CD4+↑, CD8+↑, Imm↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
Apoptosis↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, TumCG↓, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, Imm↑, 1, NF-kB↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, OS↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 14
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CD8+, CD8+ T cell
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:344 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page